• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性完全切除生长激素分泌性腺瘤:肢端肥大症是一种原发性垂体疾病的证据。

Selective total removal of a growth-hormone-secreting adenoma: evidence that acromegaly is a primary pituitary disease.

作者信息

Wanski Z J, Robinson A G, Jannetta P J

出版信息

Metabolism. 1979 Jun;28(6):624-8. doi: 10.1016/0026-0495(79)90014-3.

DOI:10.1016/0026-0495(79)90014-3
PMID:221785
Abstract

Acromegaly is caused by hypersecretion of growth hormone by the pituitary. There is some debate as to whether the primary etiology of the disease is abnormal hypothalamic stimulation of the pituitary or a primary pituitary tumor. This paper presents a case of acromegaly in which growth hormone dynamics in response to stimulation and suppression tests were abnormal. After transsphenoidal adenomectomy of a small tumor, growth hormone levels returned to normal and suppression and stimulation test results reverted to normal within 1 wk postoperatively and remained normal for 2 yr. The findings suggest that the acromegaly in this case was due to a primary pituitary dysfunction. Microsurgical removal of growth-hormone-secreting tumors provides a unique opportunity to study the etiology of acromegaly.

摘要

肢端肥大症是由垂体生长激素分泌过多引起的。关于该疾病的主要病因是下丘脑对垂体的异常刺激还是原发性垂体肿瘤,存在一些争议。本文介绍了一例肢端肥大症病例,其生长激素对刺激和抑制试验的反应动力学异常。在对一个小肿瘤进行经蝶窦腺瘤切除术后,生长激素水平恢复正常,抑制和刺激试验结果在术后1周内恢复正常,并在2年内保持正常。这些发现表明,该病例中的肢端肥大症是由原发性垂体功能障碍引起的。显微手术切除分泌生长激素的肿瘤为研究肢端肥大症的病因提供了独特的机会。

相似文献

1
Selective total removal of a growth-hormone-secreting adenoma: evidence that acromegaly is a primary pituitary disease.选择性完全切除生长激素分泌性腺瘤:肢端肥大症是一种原发性垂体疾病的证据。
Metabolism. 1979 Jun;28(6):624-8. doi: 10.1016/0026-0495(79)90014-3.
2
[Secretion of growth hormone and insulin in patients with acromegaly].[肢端肥大症患者生长激素和胰岛素的分泌]
Z Gesamte Inn Med. 1973 Mar 1;28(5):141-2 passim.
3
[Discussion of biological criteria and evaluation of therapeutic results in the relation between acromegaly and J. Hardy's gigantism].[关于肢端肥大症与J. 哈代巨人症之间关系的生物学标准及治疗结果评估的讨论]
Neurochirurgie. 1974 Sep-Oct;20(5):421-30.
4
[Treated case of temporal lobe tumor with pituitary adenoma associated with acromegaly].[垂体腺瘤合并肢端肥大症的颞叶肿瘤治疗病例]
No To Shinkei. 1967 Oct;19(10):1009-14.
5
Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.肢端肥大症:经蝶窦选择性腺瘤切除术后长期随访的治愈生化评估
J Clin Endocrinol Metab. 1985 Dec;61(6):1185-9. doi: 10.1210/jcem-61-6-1185.
6
Acromegaly in a 9 and one-half-year-old boy. Pituitary function studies before and after surgery.一名9岁半男孩患肢端肥大症。手术前后的垂体功能研究。
Am J Dis Child. 1972 May;123(5):504-6. doi: 10.1001/archpedi.1972.02110110132018.
7
Letter: Treatment of acromegaly.信件:肢端肥大症的治疗
Lancet. 1975 Jan 25;1(7900):226. doi: 10.1016/s0140-6736(75)91405-1.
8
[Control of thyrotrophic and corticotrophic functions in acromegaly].[肢端肥大症中促甲状腺激素和促肾上腺皮质激素功能的控制]
Neurochirurgie. 1973 Nov;19(6):531-6.
9
Growth hormone response to oral glucose before and after transfrontal pituitary surgery and radiotherapy in acromegaly.肢端肥大症患者经额垂体手术及放疗前后口服葡萄糖后的生长激素反应。
J Assoc Physicians India. 1986 Mar;34(3):171-3.
10
Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.肢端肥大症患者腺瘤切除前后的人胰腺生长激素释放因子(hpGRF - 44)。生长抑素(GHRIH)输注引起的变化。
J Endocrinol Invest. 1985 Oct;8(5):449-53. doi: 10.1007/BF03348536.